(1)
POSSIBILITIES OF USING RUXOLITINIB TO IMPROVE THE RESULTS OF Allo-HSCT (LITERATURE REVIEW). Вопр. онкол. 2019, 65 (3), 330-336. https://doi.org/10.37469/0507-3758-2019-65-3-330-336.